Mental Health Clinics in Weston, WI Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Drg Clinical, Sc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5703 Memorial Ct, Weston, WI 54476 Phone: 715-204-9808 |
Gregory Cowan Llc Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 3301 Cranberry Blvd, Floor 2, Weston, WI 54476 Phone: 715-393-3953 |
Balance Counseling Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2215 Schofield Ave, Box 10, Weston, WI 54476 Phone: 715-355-1088 |
Dr. David Macintyre Consulting, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2405 Schofield Ave, Suite 210, Weston, WI 54476 Phone: 715-298-2846 Fax: 715-298-3146 |
Mia Counseling Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 9103 Buska St, Weston, WI 54476 Phone: 715-575-9497 |
Skylight Autism Center Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 4601 Camp Phillips Rd, Weston, WI 54476 Phone: 715-571-1566 |
News Archive
HSV-1 exploits immune system receptor to boost infectivity and cause disease
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.
Common sleep myths may pose a significant public health threat
People often say they can get by on five or fewer hours of sleep, that snoring is harmless, and that having a drink helps you to fall asleep.
Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension
Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal.
OraVerse MAA accepted for review in five key European countries
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
Vanderbilt University orders Bruker's AVANCE III 900 US2 NMR spectrometer
Bruker, the leader in analytical magnetic resonance instrumentation, announces a major multi-systems NMR order from Vanderbilt University, including an ultra-high field AVANCE™ III 900 US2 NMR spectrometer. This purchase was made possible in large part by the American Recovery and Reinvestment Act. Vanderbilt will use these NMR instruments for a broad range of biophysical and structural analyses in biomedical research, as well as for cancer drug discovery using fragment-based approaches and structure-based drug design.
› Verified 2 days ago